Correction to: Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T

EJNMMI Phys. 2021 Apr 13;8(1):36. doi: 10.1186/s40658-021-00382-7.

Julia Brosch-Lenz¹, Carlos Uribe^{2

3}, Astrid Gosewisch⁴, Lena Kaiser⁴, Andrei Todica⁴, Harun Ilhan⁴, Franz Josef Gildehaus⁴, Peter Bartenstein⁴, Arman Rahmim^{2

3

5}, Anna Celler³, Sibylle Ziegler⁴, Guido Böning⁴

¹ Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany. Julia.BroschLenz@med.uni-muenchen.de.
² PET Functional Imaging, BC Cancer, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.
³ Department of Radiology, University of British Columbia, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.
⁴ Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistrasse 15, 81377, Munich, Germany.
⁵ Department of Integrative Oncology, BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada.

No abstract available

Publication types